SKF-89976A
SKF-89976A is a GABA transporter 1 inhibitor which is used in scientific research. It has anticonvulsant effects and may be useful in the treatment of epilepsy. SKF-89976A has also been suggested as a possible treatment for schizophrenia and dementia.
Mechanism of action[edit | edit source]
SKF-89976A works by inhibiting the GABA transporter 1 (GAT1), a protein that is responsible for the reuptake of GABA in the brain. By inhibiting this transporter, SKF-89976A increases the amount of GABA available in the brain, which can have a variety of effects.
Uses[edit | edit source]
SKF-89976A has been used in scientific research to study the role of GABA in the brain and its potential as a treatment for various conditions. It has been found to have anticonvulsant effects, suggesting it may be useful in the treatment of epilepsy. In addition, it has been suggested as a possible treatment for schizophrenia and dementia, although more research is needed in these areas.
Side effects[edit | edit source]
As with any drug, SKF-89976A can have side effects. These can include nausea, vomiting, and dizziness. However, these side effects are generally mild and go away on their own.
See also[edit | edit source]
SKF-89976A Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD